Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS, Rabkin SW, Trudeau L, Feldman RD, Cloutier L, Prebtani A, Herman RJ, Bacon SL, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Lindsay P, Hill MD, Coutts SB, Gubitz G, Gelfer M, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Burns KD, Petrella RJ, Hiremath S, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Khara M, Pipe A, Oh P, Selby P, Sharma M, Reid DJ, Tobe SW, Padwal RS, Poirier L; Canadian Hypertension Education Program.

Can J Cardiol. 2014 May;30(5):485-501. doi: 10.1016/j.cjca.2014.02.002. Epub 2014 Feb 22. Review.

2.
3.

The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension.

Hackam DG, Quinn RR, Ravani P, Rabi DM, Dasgupta K, Daskalopoulou SS, Khan NA, Herman RJ, Bacon SL, Cloutier L, Dawes M, Rabkin SW, Gilbert RE, Ruzicka M, McKay DW, Campbell TS, Grover S, Honos G, Schiffrin EL, Bolli P, Wilson TW, Feldman RD, Lindsay P, Hill MD, Gelfer M, Burns KD, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Petrella RJ, Milot A, Stone JA, Drouin D, Lavoie KL, Lamarre-Cliche M, Godwin M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk GB, Burgess E, Lewanczuk R, Dresser GK, Penner SB, Hegele RA, McFarlane PA, Sharma M, Reid DJ, Tobe SW, Poirier L, Padwal RS; Canadian Hypertension Education Program.

Can J Cardiol. 2013 May;29(5):528-42. doi: 10.1016/j.cjca.2013.01.005. Epub 2013 Mar 29.

PMID:
23541660
4.

The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Daskalopoulou SS, Khan NA, Quinn RR, Ruzicka M, McKay DW, Hackam DG, Rabkin SW, Rabi DM, Gilbert RE, Padwal RS, Dawes M, Touyz RM, Campbell TS, Cloutier L, Grover S, Honos G, Herman RJ, Schiffrin EL, Bolli P, Wilson T, Feldman RD, Lindsay MP, Hemmelgarn BR, Hill MD, Gelfer M, Burns KD, Vallée M, Prasad GV, Lebel M, McLean D, Arnold JM, Moe GW, Howlett JG, Boulanger JM, Larochelle P, Leiter LA, Jones C, Ogilvie RI, Woo V, Kaczorowski J, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Lamarre-Cliché M, Godwin M, Tremblay G, Hamet P, Fodor G, Carruthers SG, Pylypchuk G, Burgess E, Lewanczuk R, Dresser GK, Penner B, Hegele RA, McFarlane PA, Sharma M, Campbell NR, Reid D, Poirier L, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2012 May;28(3):270-87. doi: 10.1016/j.cjca.2012.02.018. Review.

PMID:
22595447
5.

The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy.

Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, Hackam DG, Myers MG, McKay DW, Quinn RR, Hemmelgarn BR, Cloutier L, Bolli P, Hill MD, Wilson T, Penner B, Burgess E, Lamarre-Cliché M, McLean D, Schiffrin EL, Honos G, Mann K, Tremblay G, Milot A, Chockalingam A, Rabkin SW, Dawes M, Touyz RM, Burns KD, Ruzicka M, Campbell NR, Vallée M, Prasad GV, Lebel M, Campbell TS, Lindsay MP, Herman RJ, Larochelle P, Feldman RD, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Lewanczuk R, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Poirier L, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2011 Jul-Aug;27(4):415-433.e1-2. doi: 10.1016/j.cjca.2011.03.015. English, French.

PMID:
21801975
6.

The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Hackam DG, Khan NA, Hemmelgarn BR, Rabkin SW, Touyz RM, Campbell NR, Padwal R, Campbell TS, Lindsay MP, Hill MD, Quinn RR, Mahon JL, Herman RJ, Schiffrin EL, Ruzicka M, Larochelle P, Feldman RD, Lebel M, Poirier L, Arnold JM, Moe GW, Howlett JG, Trudeau L, Bacon SL, Petrella RJ, Milot A, Stone JA, Drouin D, Boulanger JM, Sharma M, Hamet P, Fodor G, Dresser GK, Carruthers SG, Pylypchuk G, Burgess ED, Burns KD, Vallée M, Prasad GV, Gilbert RE, Leiter LA, Jones C, Ogilvie RI, Woo V, McFarlane PA, Hegele RA, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2010 May;26(5):249-58. Review.

7.

Blood pressure 2 years after a chronic disease management intervention study.

Tobe S, Vincent L, Wentworth J, Hildebrandt D, Kiss A, Perkins N, Hartman S, Ironstand L, Hoppe J, Hunter K, Pylypchuk G.

Int J Circumpolar Health. 2010 Feb;69(1):50-60.

PMID:
20167156
8.

DreamTel; Diabetes risk evaluation and management tele-monitoring study protocol.

Tobe SW, Wentworth J, Ironstand L, Hartman S, Hoppe J, Whiting J, Kennedy J, McAllister C, Kiss A, Perkins N, Vincent L, Pylypchuk G, Lewanczuk RZ.

BMC Endocr Disord. 2009 May 9;9:13. doi: 10.1186/1472-6823-9-13.

9.

The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy.

Khan NA, Hemmelgarn B, Herman RJ, Bell CM, Mahon JL, Leiter LA, Rabkin SW, Hill MD, Padwal R, Touyz RM, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Moe G, Prasad R, Arnold MO, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, DeChamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Bacon SL, Lindsay P, Gilbert RE, Lewanczuk RZ, Tobe S; Canadian Hypertension Education Program.

Can J Cardiol. 2009 May;25(5):287-98. Review.

10.

Diabetes risk evaluation and microalbuminuria (DREAM) studies: ten years of participatory research with a First Nation's home and community model for type 2 diabetes care in Northern Saskatchewan.

Pylypchuk G, Vincent L, Wentworth J, Kiss A, Perkins N, Hartman S, Ironstand L, Hoppe J, Tobe SW.

Int J Circumpolar Health. 2008 Jun;67(2-3):190-202. Review.

PMID:
18767339
11.

The 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Khan NA, Hemmelgarn B, Herman RJ, Rabkin SW, McAlister FA, Bell CM, Touyz RM, Padwal R, Leiter LA, Mahon JL, Hill MD, Larochelle P, Feldman RD, Schiffrin EL, Campbell NR, Arnold MO, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Ogilvie RI, Hamet P, Fodor G, Carruthers G, Burns KD, Ruzicka M, dechamplain J, Pylypchuk G, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Vallée M, Howlett J, Katzmarzyk P, Tobe S, Lewanczuk RZ; Canadian Hypertension Education Program.

Can J Cardiol. 2008 Jun;24(6):465-75. Review.

12.

IMPPACT: Investigation of Medical Professionals and Patients Achieving Control Together.

Tobe SW, Hunter K, Geerts R, Raymond N, Pylypchuk G; Canadian Hypertension Society.

Can J Cardiol. 2008 Mar;24(3):205-8.

13.

The 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.

Khan NA, Hemmelgarn B, Padwal R, Larochelle P, Mahon JL, Lewanczuk RZ, McAlister FA, Rabkin SW, Hill MD, Feldman RD, Schiffrin EL, Campbell NR, Logan AG, Arnold M, Moe G, Campbell TS, Milot A, Stone JA, Jones C, Leiter LA, Ogilvie RI, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Burns KD, Ruzicka M, deChamplain J, Pylypchuk G, Gledhill N, Petrella R, Boulanger JM, Trudeau L, Hegele RA, Woo V, McFarlane P, Touyz RM, Tobe SW; Canadian Hypertension Education Program.

Can J Cardiol. 2007 May 15;23(7):539-50.

14.

The 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part II - Therapy.

Khan NA, McAlister FA, Rabkin SW, Padwal R, Feldman RD, Campbell NR, Leiter LA, Lewanczuk RZ, Schiffrin EL, Hill MD, Arnold M, Moe G, Campbell TS, Herbert C, Milot A, Stone JA, Burgess E, Hemmelgarn B, Jones C, Larochelle P, Ogilvie RI, Houlden R, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, Dechamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Tobe S, Touyz RM; Canadian Hypertension Education Program.

Can J Cardiol. 2006 May 15;22(7):583-93.

15.
16.

The 2005 Canadian Hypertension Education Program recommendations for the management of hypertension: part II - therapy.

Khan NA, McAlister FA, Lewanczuk RZ, Touyz RM, Padwal R, Rabkin SW, Leiter LA, Lebel M, Herbert C, Schiffrin EL, Herman RJ, Hamet P, Fodor G, Carruthers G, Culleton B, DeChamplain J, Pylypchuk G, Logan AG, Gledhill N, Petrella R, Campbell NR, Arnold M, Moe G, Hill MD, Jones C, Larochelle P, Ogilvie RI, Tobe S, Houlden R, Burgess E, Feldman RD; Canadian Hypertension Education Program.

Can J Cardiol. 2005 Jun;21(8):657-72.

PMID:
16003449
17.

Use and outcomes of peritoneal dialysis among Aboriginal people in Canada.

Tonelli M, Hemmelgarn B, Manns B, Davison S, Bohm C, Gourishankar S, Pylypchuk G, Yeates K, Gill JS.

J Am Soc Nephrol. 2005 Feb;16(2):482-8. Epub 2004 Dec 8.

18.

Death and renal transplantation among Aboriginal people undergoing dialysis.

Tonelli M, Hemmelgarn B, Manns B, Pylypchuk G, Bohm C, Yeates K, Gourishankar S, Gill JS.

CMAJ. 2004 Sep 14;171(6):577-82.

19.

Rhabdomyolysis from high-dose cerivastatin therapy.

Feeney ER, Calissi PT, Pylypchuk GB.

Ann Pharmacother. 2002 Jun;36(6):1106. No abstract available.

PMID:
12058707
20.
21.

Diabetic nephropathy. Prevention and early referral.

Pylypchuk G, Beaubien E.

Can Fam Physician. 2000 Mar;46:636-42.

22.

ACE inhibitor- versus angiotensin II blocker-induced cough and angioedema.

Pylypchuk GB.

Ann Pharmacother. 1998 Oct;32(10):1060-6. Review.

PMID:
9793599
23.

Comparison of bedside- and laboratory-inoculated Bactec high- and low-volume resin bottles for the recovery of microorganisms causing peritonitis in CAPD patients.

Blondeau JM, Pylypchuk GB, Kappel JE, Pilkey B, Lawler C.

Diagn Microbiol Infect Dis. 1998 May;31(1):281-7.

PMID:
9597388
24.

Improved urea clearance raises the BUN in continuous peritoneal dialysis.

Baltzan MA, Shoker AA, Baltzan RB, Pylypchuk GB.

Clin Nephrol. 1996 Mar;45(3):183-7.

PMID:
8706360
25.

Evaluation of aerobic Bactec 6A non-resin- and 16A resin-containing media for the recovery of microorganisms causing peritonitis.

Blondeau JM, Pylypchuk GB, Kappel JE, Baltzan RB, Yaschuk Y, Adolph AJ.

Diagn Microbiol Infect Dis. 1995 Aug;22(4):361-8.

PMID:
8582145
26.

Racial influence in renal stone disease: a Saskatchewan story.

Pylypchuk G, Unger D, Wiser L, O'Reilly K, Weckworth P.

Can J Urol. 1995 Jul;2(3):159-63.

PMID:
12803714
27.

Stiff wire manipulation of peritoneal dialysis catheters.

Kappel JE, Ferguson GM, Kudel RM, Kudel TA, Lawlor BJ, Pylypchuk GB.

Adv Perit Dial. 1995;11:202-7.

PMID:
8534706
28.

A complication of ambulatory blood pressure monitoring.

Baetz MD, Pylypchuk G, Baetz M.

Ann Intern Med. 1994 Sep 15;121(6):468-9. No abstract available.

PMID:
8053627
29.

Cough induced by quinapril with resolution after changing to fosinopril.

Sharif MN, Evans BL, Pylypchuk GB.

Ann Pharmacother. 1994 Jun;28(6):720-2.

PMID:
7919557
30.

Sensitivity of CAPD/IPD peritonitis organisms to ciprofloxacin.

Pylypchuk GB, Conly J, Kappel JE, Stein K, Rennie R.

Adv Perit Dial. 1991;7:135-7.

PMID:
1680410
31.

HLA matching enhances long-term renal graft survival but does not relate to acute rejection.

Baltzan MA, Baltzan RB, Baltzan BL, Cunningham TC, Pylypchuk GB, Dyck RF, West ML.

Medicine (Baltimore). 1990 Jul;69(4):227-31.

PMID:
2374507
35.

Calcium metabolism in adult outpatients with epilepsy receiving long-term anticonvulsant therapy.

Pylypchuk G, Oreopoulos DG, Wilson DR, Harrison JE, McNeill KG, Meema HE, Ogilvie R, Sturtridge WC, Murray TM.

Can Med Assoc J. 1978 Mar 18;118(6):635-8.

36.

Home peritoneal dialysis: 3 years' experience in Toronto.

Karanicolas S, Oreopoulos DG, Pylypchuk G, Fenton SS, Cattran DC, Rapoport A, de Veber GA.

Can Med Assoc J. 1977 Feb 5;116(3):266-9.

Supplemental Content

Loading ...
Support Center